Stay updated on Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision 3.5.0 has been added to the record history, and revision 3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:57.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page history shows a new site revision v3.4.3 added and the previous revision v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:19:03.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and an older funding-status notice and revision entry (v3.4.1) were removed as administrative updates.
    Difference
    0.7%
    Check dated 2026-02-11T11:47:51.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide notice about potential data delays due to a lapse in government funding was added, and the record version was updated from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-04T06:20:06.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    UI changes include a Show glossary option, color-coded highlights for additions and deletions (green for additions, red for deletions), and a revision label; these formatting updates do not affect study data, and to avoid being alerted by small changes, set an alert condition below.
    Difference
    0.9%
    Check dated 2026-01-28T04:28:17.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; these are minor version metadata updates that do not affect study information on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:51:48.000Z thumbnail image

Stay in the know with updates to Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.